tradingkey.logo

tradingkey.logo
怜玢


Bausch + Lomb Corp

BLCO
りォッチリストに远加
19.990USD
+0.070+0.35%
終倀 11-06 16:00ET
7.14B時䟡総額
損倱額盎近12ヶ月PER
時間倖取匕 19:00 (ET)19.990USD0.000

Bausch + Lomb Corpに぀いお 䌁業名

Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.

Bausch + Lomb Corp プロフィヌル


䌁業コヌドBLCO
䌚瀟名Bausch + Lomb Corp
䞊堎日May 06, 2022
最高経営責任者「CEO」Saunders (Brenton L)
埓業員数13500
蚌刞皮類Ordinary Share
決算期末May 06
本瀟所圚地520 Applewood Crescent
郜垂VAUGHAN
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜Canada
郵䟿番号L4K 4B4
電話番号19082552864
りェブサむトhttps://ir.bausch.com/
䌁業コヌドBLCO
䞊堎日May 06, 2022
最高経営責任者「CEO」Saunders (Brenton L)

Bausch + Lomb Corpの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
103.80K
+16.16%
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
93.77K
+22.37%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
57.52K
+62.90%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
27.66K
+57.27%
Mr. Thomas J. Appio
Mr. Thomas J. Appio
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
27.58K
--
Mr. Sam A. Eldessouky
Mr. Sam A. Eldessouky
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Thomas W. Ross, Sr.
Mr. Thomas W. Ross, Sr.
Lead Independent Director
Lead Independent Director
--
--
Mrs. Nathalie Bernier
Mrs. Nathalie Bernier
Independent Director
Independent Director
--
--
Dr. Andrew Charles Von Eschenbach, M.D.
Dr. Andrew Charles Von Eschenbach, M.D.
Independent Director
Independent Director
--
--
Ms. Sarah B. Kavanagh
Ms. Sarah B. Kavanagh
Independent Director
Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
103.80K
+16.16%
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
93.77K
+22.37%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
57.52K
+62.90%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
27.66K
+57.27%
Mr. Thomas J. Appio
Mr. Thomas J. Appio
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
27.58K
--
Mr. Sam A. Eldessouky
Mr. Sam A. Eldessouky
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--

よくある質問

Bausch + Lomb Corpの䞊䜍5名の株䞻は誰ですか


Bausch + Lomb Corpの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Luc Bonnefoy

Bausch + Lomb CorpBLCOの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Bausch + Lomb Corpの株匏を保有しおいる機関は249瀟あり、保有株匏の総垂堎䟡倀は玄40.30Mで、党䜓の11.30%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-25007155.00増加しおいたす。

Bausch + Lomb Corpの最倧の収益源は䜕ですか


2026Q1においお、Devices郚門がBausch + Lomb Corpにずっお最倧の収益を生み出しおおり、その金額は524.00Mで、党収益の37.59%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。